Medlive Technology Co., Ltd.

SZSC:2192 Stock Report

Market Cap: HK$6.3b

Medlive Technology Past Earnings Performance

Past criteria checks 4/6

Medlive Technology has been growing earnings at an average annual rate of 41.2%, while the Healthcare Services industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 22.6% per year. Medlive Technology's return on equity is 5.4%, and it has net margins of 58.8%.

Key information

41.2%

Earnings growth rate

34.2%

EPS growth rate

Healthcare Services Industry Growth22.3%
Revenue growth rate22.6%
Return on equity5.4%
Net Margin58.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Medlive Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSC:2192 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 234122421770
30 Sep 233842161670
30 Jun 233561891570
31 Mar 233351531540
31 Dec 223141171510
30 Sep 22300831430
30 Jun 22286481350
31 Mar 22285441310
31 Dec 21284411280
30 Sep 21270551090
30 Jun 2125570890
31 Mar 2123478710
31 Dec 2021485530
31 Dec 1912231370
31 Dec 188314310

Quality Earnings: 2192 has a high level of non-cash earnings.

Growing Profit Margin: 2192's current net profit margins (58.8%) are higher than last year (37.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2192's earnings have grown significantly by 41.2% per year over the past 5 years.

Accelerating Growth: 2192's earnings growth over the past year (106.5%) exceeds its 5-year average (41.2% per year).

Earnings vs Industry: 2192 earnings growth over the past year (106.5%) exceeded the Healthcare Services industry 13.5%.


Return on Equity

High ROE: 2192's Return on Equity (5.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.